3D Bioprinting of Tumor Models for Cancer Research
The DOI matches its Crossref record; 239 of the 241 references it cites were found in a registry or an index.
Abstract
The exact mechanistic understanding of cancer metastasis continues to be unknown, although it is a major cause of death worldwide. Along with the tumor mass, the tumor microenvironment also contributes to pathogenesis and treatment resistance. Tumors are characterized by a high degree of heterogeneity and complexity. However, the fabrication of suitable in vitro models of the microenvironment is difficult as two-dimensional (2D) models do not completely recapitulate the biochemical and biophysical signals of the tumor environment. Thus, three-dimensional (3D) tumor models are emerging as vital tools for the comprehensive understanding of the sophisticated disease. Among different 3D models such as spheroid cultures, biopolymer scaffolds, organ on chip, and ex vivo tissue slices, 3D bioprinting has a competitive advantage due to the ability to precisely control and define the desired structure and position of multiple types of cells in a high-throughput manner. In this Review, we discussed the 3D bioprinted tumor models that integrate their microenvironment with different cell types, substrates, and bioprinting modalities and their application in drug screening and therapy. Finally, we highlighted the comprehensive understanding of the cancer microenvironment by 3D printed tumor models that are more physiologically relevant than the other models and expounded the challenges that need to be addressed for the clinical translation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Alginate hydrogels as synthetic extracellular matrix materials
Rowley, J. A., Madlambayan, G., & Mooney, D. J. (1999) · Biomaterials · doi:10.1016/s0142-9612(98)00107-0 · Cited by 2,342
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014) · Advanced Materials · doi:10.1002/adma.201305506 · Cited by 2,102
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Research works printed but not linked: 6
- Cirri P., 2011, Am. J. Cancer Res., 1, 482
- Soranzo C., 1998, Anticancer Res., 8, 369
- Langmuir V. K., 1989, Cancer Res., 49, 3401
- Jin Y., 2015, Int. J. Clin. Exp. Med., 8, 9911
- 10.1088/1758-5082/6/3/035001 · DOI · Paper page
- 10.1088/1758-5090/aafc49 · DOI · Paper page
Cited by
3D bioprinting and its innovative approach for biomedical applications
Tripathi, S., Mandal, S. S., Bauri, S., & Maiti, P. (2023) · MedComm · doi:10.1002/mco2.194 · Cited by 206
Drug screening at single-organoid resolution via bioprinting and interferometry
Tebon, P. J., Wang, B., Markowitz, A. L., Davarifar, A., Tsai, B. L., Krawczuk, P., Gonzalez, A. E., Sartini, S., Murray, G. F., Nguyen, H. T. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38832-8 · Cited by 182
Multimaterial 3D and 4D Bioprinting of Heterogenous Constructs for Tissue Engineering
Chen, A., Wang, W., Mao, Z., He, Y., Chen, S., Liu, G., Su, J. D., Feng, P., Shi, Y., Yan, C., et al. (2023) · Advanced Materials · doi:10.1002/adma.202307686 · Cited by 180
Drug screening at single-organoid resolution via bioprinting and interferometry
Tebon, P. J., Wang, B., Markowitz, A. L., Davarifar, A., Krawczuk, P., Murray, G., Nguyen, H. T. L., Tavanaie, N., Nguyen, T. L., Boutros, P. C., et al. (2021) · doi:10.1101/2021.10.03.462896 · Cited by 155
Osouli-Bostanabad, K., Masalehdan, T., Kapsa, R. M. I., Quigley, A. F., Lalatsa, A., Bruggeman, K. F., Franks, S. J., Williams, R. J., & Nisbet, D. R. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00094 · Cited by 111
Laser-induced forward transfer based laser bioprinting in biomedical applications
Chang, J., & Sun, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1255782 · Cited by 102
“The biomaterials surrounding cells in 3D cell printing can mimic the functionality of the extracellular matrix in the body, providing a suitable microenvironment for cell survival, proliferation, and differentiation (Kang et al., 2020; Mota et al., 2020; Wu et al., 2022).”
BackgroundShi, W., Mirza, S., Kuss, M. A., Liu, B., Hartin, A., Wan, S., Kong, Y., Mohapatra, B. C., Krishnan, M. A., Band, H., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300905 · Cited by 102
Advanced usage of Ti3C2Tx MXenes for photothermal therapy on different 3D breast cancer models
Perini, G., Rosenkranz, A., Friggeri, G., Zambrano-Mera, D. F., Rosa, E., Augello, A., Palmieri, V., Spirito, M. D., & Papi, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113496 · Cited by 88
“Subsequently, we bio-printed a 3D cancer model, in which 4T1 breast cancer cells were embedded in a matrix resembling ECM [23,29 – 31].”
3D bioprinting strategy for engineering vascularized tissue models
Chae, S., Ha, D., & Lee, H. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.748 · Cited by 88
“However, conventional tumor models are known to be sub-optimal in realizing human cancer physiology, which imposes tremendous constraints on the anticancer drug efficacy[57,58].”
3D bioprinting complex models of cancer
Sharma, R., Perez, M. R., da Silva, V. A., Thomsen, J., Bhardwaj, L., de Andrade, T. A. M., Alhussan, A., & Willerth, S. M. (2023) · Biomaterials Science · doi:10.1039/d2bm02060b · Cited by 86
3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models
Monteiro, M. V., Zhang, Y. S., Gaspar, V. M., & Mano, J. F. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.08.007 · Cited by 82
Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment
Zhuang, P., Chiang, Y., Fernanda, M. S., & He, M. L. (2024) · International Journal of Bioprinting · doi:10.18063/ijb.v7i4.444 · Cited by 80
“3D bioprinting possesses superior flexibility and controllability on the spatial arrangement of biomaterials and cells, which has been expansively applied to tumor-related studies including TME mimicking, tumor angiogenesis, tumor metastasis, and antitumor drug screening using individual cells and miscellaneous biomat…”
BackgroundSilvani, G., Basirun, C., Wu, H., Mehner, C., Poole, K., Bradbury, P., & Chou, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100106 · Cited by 80
Precision biomaterials in cancer theranostics and modelling
Caballero, D., Abreu, C. M., Lima, A. C., Neves, N. M., Reis, R. L., & Kundu, S. C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121299 · Cited by 72
Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues
Hwangbo, H., Chae, S., Kim, W.-J., Jo, S., & Kim, G. (2023) · Theranostics · doi:10.7150/thno.90093 · Cited by 73
“By connecting the potential of 3D bioprinting, spheroids, microfluidic systems, and hybrid fabrication approaches, researchers have paved the way for more advanced and sophisticated tumor-on-a-chip models [40, 68-70].”
BackgroundNing, L., Shim, J., Tomov, M. L., Liu, R., Mehta, R., Mingee, A., Hwang, B., Jin, L., Mantalaris, A., Xu, C., et al. (2022) · Advanced Science · doi:10.1002/advs.202200244 · Cited by 67
Gong, Z., Huang, L., Tang, X., Chen, K., Wu, Z., Zhang, L., Sun, Y., Xia, Y., Chen, H., Wei, Y., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101312 · Cited by 62
Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management
Pandey-Tiwari, A., Thorat, N. D., Pricl, S., Patil, R. M., Rohiwal, S. S., & Townley, H. E. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.010 · Cited by 61
Recent progress of 4D printing in cancer therapeutics studies
Chinnakorn, A., Nuansing, W., Bodaghi, M., Rolfe, B., & Zolfagharian, A. (2023) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2023.02.002 · Cited by 55
Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
Moghimi, N., Hosseini, S. A., Dalan, A. B., Mohammadrezaei, D., Goldman, A. J., & Kohandel, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40680-x · Cited by 60
The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Fröhlich, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087116 · Cited by 57
3D Bioprinting in Otolaryngology: A Review
McMillan, A., McMillan, N., Gupta, N., Kanotra, S. P., & Salem, A. K. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203268 · Cited by 51
Kim, J., Jang, J., & Cho, D. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.605819 · Cited by 44
“With their ability to mimic in vivo environments, and the automated model fabrication process, 3D cell-printed cancer models have become prominent candidates to replace animal models (Kang et al., 2020).”
Background3D-Printed Medical Implants: Recent Trends and Challenges
Alam, M. I., Kashyap, S., Balaji, P. G., Yadav, A. K., & Flora, S. J. S. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00221-0 · Cited by 50
“However, advancements in cancer research have enabled the close mimicry of the actual tumor microenvironment using 3D-tumor models, offering valuable insights into cancer detection, drug screening, and translational research [52].”
Orr, A., Kalantarnia, F., Nazir, S., Bolandi, B., Alderson, D., O’Grady, K., Hoorfar, M., Julian, L. M., & Willerth, S. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115524 · Cited by 45
Evaluation of Proton-Induced DNA Damage in 3D-Engineered Glioblastoma Microenvironments
Akolawala, Q., Rovituso, M., Versteeg, H. H., Rondon, A. M. R., & Accardo, A. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c03706 · Cited by 40
3D Bioprinting of Nature-Inspired Hydrogel Inks Based on Synthetic Polymers
Kumar, S., Tharayil, A., & Thomas, S. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c00567 · Cited by 38
Trends in Photopolymerizable Bioinks for 3D Bioprinting of Tumor Models
Gugulothu, S. B., Asthana, S., Homer‐Vanniasinkam, S., & Chatterjee, K. (2023) · JACS Au · doi:10.1021/jacsau.3c00281 · Cited by 37
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 36
Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma
Vázquez‐Aristizabal, P., Henriksen‐Lacey, M., García‐Astrain, C., de Aberasturi, D. J., Langer, J., Epelde, C., Litti, L., Liz‐Marzán, L. M., & Izeta, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401136 · Cited by 38
3D bioprinting approaches for enhancing stem cell-based neural tissue regeneration
Bektas, C. K., Luo, J., Conley, B., Le, K.-P. N., & Lee, K. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.006 · Cited by 39
Dey, M., Kim, M. H., Nagamine, M., Karhan, E., Kozhaya, L., Dogan, M., Unutmaz, D., & Ozbolat, I. T. (2022) · Biofabrication · doi:10.1088/1758-5090/ac925a · Cited by 35
“Studying immune–cancer interactions in different 3D tumor models with increasing complexity is essential for understanding the range of immune response and how it varies on introducing various complexities in 3D models [36, 37].”
Self-citation3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research
Antonelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310620 · Cited by 37
Ozbek, I. I., Saybaşılı, H., & Ülgen, K. Ö. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01569 · Cited by 37
Liu, S., & Jin, P. (2025) · Polymers · doi:10.3390/polym17070948 · Cited by 37
“To reconcile the discrepancies between cultures and animal models, 3D reconcile the discrepancies between 2D cultures and animal models, 3D culture models have been innovated [1]. culture models have been innovated [1].”
Salerno, A., & Netti, P. A. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.682133 · Cited by 31
Key aspects for conception and construction of co-culture models of tumor-stroma interactions
Mason, J. E., & Öhlund, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1150764 · Cited by 32
“The ability to print in 3D using relatively simple materials has been important in the industrial sector at large, but also can be adapted for use in a cancer context, which is reviewed in depth excellently elsewhere (Datta et al., 2020; Kang et al., 2020; Augustine et al., 2021).”
BackgroundIn Situ Fabrication of Constraints for Multicellular Micro‐Spheroids Using Two‐Photon Lithography
Taale, M., Schamberger, B., Taheri, F., Antonelli, Y., Leal‐Egaña, A., & Selhuber‐Unkel, C. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302356 · Cited by 29
Devin, A. B. S., Keshavarzi, A., Hemami, A. A., Bashipour, A. F., & Googarchin, H. S. (2025) · Thin-Walled Structures · doi:10.1016/j.tws.2025.113684 · Cited by 37
Advances in screening hyperthermic nanomedicines in 3D tumor models
Soeiro, J. F., Sousa, F. L., Monteiro, M. V., Gaspar, V. M., Silva, N. J. O., & Mano, J. F. (2024) · Nanoscale Horizons · doi:10.1039/d3nh00305a · Cited by 30
3D Bioprinting of Model Tissues That Mimic the Tumor Microenvironment
Bojin, F. M., Robu, A., Bejenariu, M. I., Ordodi, V. L., Olteanu, G., Cean, A., Popescu, R., Neagu, M., Gavriliuc, O. I., Neagu, A., et al. (2021) · Micromachines · doi:10.3390/mi12050535 · Cited by 28
Chae, S., & Cho, D. (2022) · MRS Bulletin · doi:10.1557/s43577-021-00260-8 · Cited by 28
Applications of 3D Bio-Printing in Tissue Engineering and Biomedicine
Jiang, W., Mei, H., & Zhao, S. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3078 · Cited by 25
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion
Staros, R., Michalak, A., Rusinek, K., Mucha, K., Pojda, Z., & Zagożdżon, R. (2022) · Cancers · doi:10.3390/cancers14133126 · Cited by 25
Next generation bioprinting with artificial intelligence in the healthcare industry
Dhiman, B., Bammidi, R., Kumar, M., Rangappa, S. M., & Siengchin, S. (2026) · Next Bioengineering · doi:10.1016/j.nxbio.2026.100015 · Cited by 27
Khoshtabiat, L., Meshkini, A., & Matin, M. M. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00188-5 · Cited by 23
A layered cancer-on-a-chip system for anticancer drug screening and disease modeling
Flont, M., Dybko, A., & Jastrzębska, E. (2023) · The Analyst · doi:10.1039/d3an00959a · Cited by 21
Characterization of 3D-Bioprinted In Vitro Lung Cancer Models Using RNA-Sequencing Techniques
Zou, S., Ye, J., Wei, Y., & Xu, J. (2023) · Bioengineering · doi:10.3390/bioengineering10060667 · Cited by 22
Engineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
Monteiro, M. V., Rocha, M., Carvalho, M. T., Freitas, I., Amaral, A. J. R., Sousa, F. L., Gaspar, V. M., & Mano, J. F. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c11188 · Cited by 20
Carnevali, F., Forciniti, S., Onesto, V., Siciliano, A. C., Iuele, H., Grasso, G., da Cruz, A. F., Serra, I., Depalma, N., D’Ugo, S., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400351 · Cited by 20
Radiotherapy Resistance of 3D Bioprinted Glioma via ITGA2/p‐AKT Signaling Pathway
Liu, D., Tian, H., Li, H., Nie, J., Han, Z., Tang, G., Gao, P., Cheng, H., & Dai, X. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303394 · Cited by 18
A Novel 3D‐Bioprinting Technology of Orderly Extruded Multi‐Materials via Photopolymerization
Negrete, J. A. T., Babayiğit, C., Najafikoshnoo, S., Lee, S. W., Boyraz, O., & Esfandyarpour, R. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201926 · Cited by 18
Akolawala, Q., Keuning, F., Rovituso, M., van Burik, W., van der Wal, E., Versteeg, H. H., Rondon, A. M. R., & Accardo, A. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302988 · Cited by 22
Advancement in Cancer Vasculogenesis Modeling through 3D Bioprinting Technology
Shukla, A. K., Yoon, S., Oh, S., Lee, D., Ahn, M., & Kim, B. S. (2024) · Biomimetics · doi:10.3390/biomimetics9050306 · Cited by 18
“A significant feature of this research is the characterization of the anatomical and functional properties of the vasculature found within the tumor microenvironment [138–141].”
BackgroundCancer Stem Cell Microenvironment Models with Biomaterial Scaffolds In Vitro
Hassan, G., Afify, S. M., Kitano, S., Seno, A., Ishii, H., Shang, Y., Matsusaki, M., & Seno, M. (2020) · Processes · doi:10.3390/pr9010045 · Cited by 21
Size-dependent penetration depth of colloidal nanoparticles into cell spheroids
Zhu, D., Brückner, D., Sosniok, M., Skiba, M., Feliu, N., Gallego, M., Liu, Y., Schulz, F., Falkenberg, G., Parak, W. J., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115593 · Cited by 17
In Vitro Human Cancer Models for Biomedical Applications
Choi, J. R., Kozalak, G., di Bari, I., Babar, Q., Niknam, Z., Rasmi, Y., & Yong, K. W. (2022) · Cancers · doi:10.3390/cancers14092284 · Cited by 17
Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
Kim, J., Jang, J., & Cho, D. (2021) · Micromachines · doi:10.3390/mi12091122 · Cited by 13
3D printing to construct in vitro multicellular models of melanoma
Sang, S., Wang, X., Duan, J., Cao, Y., Shen, Z., Sun, L., Duan, Q., & Liu, Z. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28429 · Cited by 13
Hong, S., & Song, J. M. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c17877 · Cited by 14
Characterization of two different alginate-based bioinks and the influence of melanoma growth within
Schipka, R., Heltmann‐Meyer, S., Schneidereit, D., Friedrich, O., Röder, J., Boccaccini, A. R., Schrüfer, S., Schubert, D. W., Horch, R. E., Bosserhoff, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63642-3 · Cited by 12
Sarvari, S., McGee, D. S., O’Connell, R. C., Tseytlin, O., Bobko, A. A., & Tseytlin, M. (2023) · Molecular Imaging and Biology · doi:10.1007/s11307-023-01871-0 · Cited by 12
“Human-relevant models are created that expand our knowledge of the underlying pathological mechanisms in diseases [3–7].”
BackgroundGao, H., Peng, W., Zhou, Y., Ding, Z., Su, M., Wu, Z., & Yu, C. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116610 · Cited by 11
Liu, W., Hu, R., Han, K., Sun, M., Liu, D., Zhang, J., & Wang, J. (2021) · Biotechnology Journal · doi:10.1002/biot.202000655 · Cited by 12
Shukla, P., Bera, A. K., Yeleswarapu, S., & Pati, F. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202400035 · Cited by 12
Recapitulating the Cancer‐Immunity Cycle on a Chip
Lee, Y., Min, J., Kim, S., Park, W., Ko, J., & Jeon, N. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401927 · Cited by 11
4D printed hydrogels for precision delivery of bioactive molecules in cancer
Gato-Diaz, U., Concheiro, Á., Alvarez‐Lorenzo, C., & Blanco‐Fernandez, B. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2539959 · Cited by 11
“Another important aspect is their capacity to reproduce the dynamic changes that occur in the TME components during tumor progression, from initial development to metastasis [124].”
Tumor-on-chip’s alliance with molecular pathology against metastatic disease
Carlo, E. D. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01209-8 · Cited by 10
“Layer-by-layer bio-printing enables controlled placement of tumor cells, stromal cells, endothelial channels, and ECM gradients, permitting construction of metastatic niches (e.g., pre-metastatic niche, intravasation sites) [89].”
Eckert, C., Schmidt, S., Faber, J., Detsch, R., Vielreicher, M., Lamberger, Z., Stahlhut, P., Sandor, E., Karimi, T., Schmid, R., et al. (2025) · Bioprinting · doi:10.1016/j.bprint.2024.e00384 · Cited by 9
Bioprinting: A Strategy to Build Informative Models of Exposure and Disease
Cáceres-Albán, J., Sanchez, M., & Casado, F. L. (2022) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2022.3146293 · Cited by 11
“Bioprinted cancer models present a number of advantages including: 1) spatial control of matrix properties that include stiffness and diffusion of biochemical factors, 2) integration of perfusable vascular networks, and 3) automated high-throughput fabrication [164], [165].”
BackgroundUsing 3D-bioprinted models to study pediatric neural crest-derived tumors
Quinn, C. H., Beierle, A. M., Julson, J. R., Erwin, M. H., Alrefai, H., Markert, H. R., Stewart, J. E., Hutchins, S. C., Bownes, L. V., Aye, J. M., et al. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.723 · Cited by 10
Sun, H., Wang, Y., & Yang, H. (2023) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-248 · Cited by 11
“The advent of 3D bioprinting technology has opened up new avenues for studying tumor models of clinical significance (9).”
Spheroid‐on‐a‐Chip Platforms for Tumor Microenvironment and Drug Development
Uzabakiriho, P. C., Jiajun, F., Nguchu, B. A., Iqbal, S., Manishimwe, C., & Shaw, P. M. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202401821 · Cited by 9
Crosslinking Agents in the Targeted Design of Chitosan-Based Materials
Кильдеева, Н. Р., Privar, Y. O., & Bratskaya, S. Y. (2025) · Colloid Journal · doi:10.1134/s1061933x25601362 · Cited by 8
Srinivasan, D., Gout, J., Kleger, A., & Roger, É. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115697 · Cited by 11
Bridging high resolution sub-cellular imaging with physiologically relevant engineered tissues
Kooh, Y. K. G., & Huebsch, N. (2024) · Frontiers in Mechanical Engineering · doi:10.3389/fmech.2024.1481933 · Cited by 7
Foong, J. J. Y. W., Febriansyah, B., Rana, P. J. S., Koh, T. M., Tay, D. J. J., Bruno, A., Mhaisalkar, S. G., & Mathews, N. (2021) · ChemSusChem · doi:10.1002/cssc.202002831 · Cited by 7
Quílez, C., Cerdeira, E., González‐Rico, J., Izuzquiza, G. D. A., López-Donaire, M. L., Jorcano, J. L., & Velasco, D. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac7a7f · Cited by 10
“For this reason, most of the articles regarding spheroid bioprinting mostly involve extrusion-based bioprinting [26, 27], with laserbased bioprinting used to a minor extent [28, 29].”
BackgroundVascularization ability of glioma stem cells in different three-dimensional microenvironments
Wang, X., Xu, T., & Niu, C. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad094 · Cited by 6
Yao, L., Pei-lin, X., Huang, T., Xiao, J., Zhu, Z., Liu, S., Wang, T., & Qi, T. (2026) · Biotechnology Journal · doi:10.1002/biot.70267 · Cited by 5
3D puzzle-inspired construction of large and complex organ structures for tissue engineering
Xie, Z., Zeng, J., Miyagawa, S., Sawa, Y., & Matsusaki, M. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100726 · Cited by 8
“With the rapid development of 3D printing in the past decade, extensive research has been conducted into attempts to fabricate tissue models based on 3D bioprinting, such as muscle [13], brain [14], tumor [15], vessel models [16–19], and simple organ structures including cartilage [20,21], ear [22], nose, and even a s…”
MethodNext-Generation models of Gallbladder Carcinoma: Linking biological insights to precision medicine
Sahoo, O. S., Minocha, R., Kumar, D., Nayek, A., Singh, G., Bhardwaj, N., Sarkar, S. K., Nayak, N. R., Dhar, R., & Karmakar, S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104827 · Cited by 6
Introduction to bioprinting of in vitro cancer models
Yi, H. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200104 · Cited by 5
Lin, M., Jiang, D., Zhang, X., & Kang, Y. Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505819 · Cited by 4
Self-citationFabrication of Bioactive Structures from Sol–Gel Derived Bioactive Glass
Durgalakshmi, D., & Kumar, A. (2022) · Wiley eBooks · doi:10.1002/9781119724193.ch6 · Cited by 7
Advancing 3D-bioprinting with photopolymerization of orderly extruded multi-materials (POEM)
Babayiğit, C., Negrete, J. A. T., Najafikhoshnoo, S., Esfandyarpour, R., & Boyraz, O. (2024) · Laser 3D Manufacturing · doi:10.1117/12.3001117 · Cited by 3
“Notably, engineering artificial tissues and organs from cells significantly advances drug screening 1 , disease modeling 2 , high throughput assays 3 , cancer research 4 , and clinical transplantation 5 .”
BackgroundRecent advances in 3D printing applications for CNS tumours
Awuah, W. A., Karkhanis, S., Ben-Jaafar, A., Kong, J. S. H., Mannan, K. M., Nkrumah-Boateng, P. A., Tan, J. K., Adeleke, O. A., Shet, V., Shah, M. H., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02483-w · Cited by 3
“This approach better mimics cellular heterogeneity and tumour behaviour [50].”
Amens, J. N., Yang, J., Hawthorne, L., & Zorlutuna, P. (2025) · Biomaterials Science · doi:10.1039/d4bm01569j · Cited by 5
Core–shell microbead-based 3D vascularized glioma tumor model for effective drug testing
Zhang, X., Wang, Z., Liu, Z., Zhan, Z., Chen, J., & Xu, T. (2025) · Biofabrication · doi:10.1088/1758-5090/adebb5 · Cited by 2
“Numerous fabrication strategies have been developed for cancer models [4].”
Becceneri, A. B., Liu, S., Yıldırım, S., Kim, M. H., Liu, Y., Namlı, İ., Umstead, T. M., Chroneos, Z. C., da Silva, R. S., & Ozbolat, I. T. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103348 · Cited by 2
“This enhanced physiological relevance makes 3D models a valuable platform for investigating tumor biology and evaluating the efficacy of anticancer therapies [12,14,15].”
Self-citation4D Printing: The Next Dimension of Healthcare in Cancer Research
Chinnakorn, A., Nuansing, W., Kouzani, A. Z., Bodaghi, M., & Zolfagharian, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2404-2_7 · Cited by 2
Characterization of Bioinks for 3D Bioprinting
Saha, S., & Datta, P. (2021) · Gels horizons: from science to smart materials · doi:10.1007/978-981-16-4667-6_2 · Cited by 3
Self-citationThree-dimensional bio-printed microtissues: precision medicine approach in primary liver cancer
Alikhani, H. K., Seydi, H., Nouri, K., Majidi, F., Smirnova, O., Heydari, Z., Kuznetsova, D. S., Shpichka, A. I., Rismani, E., Timashev, P. S., et al. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2595850 · Cited by 2
Geng, Y., Wang, Y., Meng, Q., Huang, N., Huang, S., & Chen, X. (2026) · New Journal of Chemistry · doi:10.1039/d6nj00254d · Cited by 1
Scrocciolani, C., Caserio, L., Grillo, S., Ottavi, F., Masi, I., Jacchetti, E., Vangosa, F. B., Raimondi, M. T., Colosimo, B. M., Rosanò, L., et al. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00299 · Cited by 2
Gugulothu, S. B., & Chatterjee, K. (2026) · Engineered Regeneration · doi:10.1016/j.engreg.2026.07.002 · Cited by 1
Bioprinting in Pharmaceuticals
Dixit, M., Singh, N., Das, P., & Datta, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-2404-2_9 · Cited by 1
Self-citationThree dimensional bioprinted models for drug screening cancer metastasis and prognosis study
Khuntia, A., Dash, S., Swain, S. S., & Sahoo, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00011-2 · Cited by 1
Contact Line Dynamics and Droplet Spreading
Karim, A. M. (2025) · Fluids · doi:10.3390/fluids10080206 · Cited by 1
Metadata
- Authors
- Kang, Y., Datta, P., Shanmughapriya, S., & Ozbolat, I. T.
- Affiliations
- The Huck Institutes of the Life Sciences, Penn State University, University Park, Pennsylvania 16802, United States
- Indian Institute of Engineering Science and Technology, Shibpur (IN)
- Pennsylvania State University (US)
- Corresponding author
- Ozbolat, Ibrahim T.
- Venue
- ACS Applied Bio Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-08-10
- Volume
- 3
- Issue
- 9
- Pages
- 5552-5573
- ISSN
- 2576-6422 (ISSN-L)
- OpenAlex
- W3048874737
- Cited by
- 112
- References
- 241
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 18 · 2023: 32 · 2022: 13 · 2021: 16 · 2020: 1
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Applied Bio Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R21 CA224422)
- Department of Science and Technology, Ministry of Science and Technology
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- 3D bioprinting, tumor models, tumor microenvironment, metastasis, tumor heterogeneity, spheroid culture, biopolymer scaffolds, organ-on-a-chip, drug screening, cancer therapy, clinical translation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.